Crispr Infuses First Human in Landmark Gene-Editing Study
Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.
from NDTV Gadgets - Latest {
from NDTV Gadgets - Latest {
కామెంట్లు
కామెంట్ను పోస్ట్ చేయండి